Component
Lycopene concentration in prostate tissue
Lycopene concentration in prostate tissue. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Supplementation increased prostate lycopene from 0.45 to 0.59 pmol/mg and plasma lycopene from 0.74 to 1.43 micromolar.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/21430075.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c1351b40c0701ce0b8e35bc9346b63650fbd2ee3a9263091aa6b304b9860a5e3", "start_char": 0, "end_char": 1314, "text_sha256": "c1351b40c0701ce0b8e35bc9346b63650fbd2ee3a9263091aa6b304b9860a5e3"}
- experimental_model
- Double-blind placebo-controlled prebiopsy trial
- exposure
- 30 mg/day tomato-oleoresin lycopene for 21 days
- limitations
- Short exposure; tissue and oxidation biomarkers do not establish cancer prevention or clinical benefit.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, 105 African American male veterans
- plain_language
- The substance reached the tissue; delivery alone does not prove benefit.
- primary_references
- [lycopene-p21430075] Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21430075/ DOI: 10.1158/1940-6207.capr-10-0288
- tissue_or_cell_type
- Plasma and prostate biopsy
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 1079–1090
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled prebiopsy trial · source_derived_draft · unverified_draft
### lycopene-prostate-delivery Supplementation increased prostate lycopene from 0.45 to 0.59 pmol/mg and plasma lycopene from 0.74 to 1.43 micromolar. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The substance reached the tissue; delivery alone does not prove benefit. organism: Human, 105 African American male veterans tissue_or_cell_type: Plasma and prostate biopsy experimental_model: Double-blind placebo-controlled prebiopsy trial limitations: Short exposure; tissue and oxidation biomarkers do not establish cancer prevention or clinical benefit. exposure: 30 mg/day tomato-oleoresin lycopene for 21 days evidence_span: {"source_cache": "artifacts/lycopene-research/21430075.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c1351b40c0701ce0b8e35bc9346b63650fbd2ee3a9263091aa6b304b9860a5e3", "start_char": 0, "end_char": 1314, "text_sha256": "c1351b40c0701ce0b8e35bc9346b63650fbd2ee3a9263091aa6b304b9860a5e3"} [lycopene-p21430075] Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21430075/ DOI: 10.1158/1940-6207.capr-10-0288
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.